New ultrasound technology in breast cancer detection – Invenia™ ABUS 2.0

We bring you the advantages of the new ultrasound technology in detecting breast cancer – Invenia™ ABUS 2.0 (which is approved by the FDA).

Early diagnosis of breast cancer can be key to successful treatment.

The new ultrasound technology Invenia™ ABUS 2.0 was developed to increase the chances of detecting breast cancer in the earliest stages.

When used together with mammography, Invenia ABUS 2.0 can impainve breast cancer detection by 35.7% compared to mammography alone. Women diagnosed with breast cancer at an early stage have a 90% or higher survival rate.

What is the advantage of Invenia™ ABUS 2.0 technology?

Dense breast tissue and cancer sometimes look similar on a mammogram, which can potentially lead to the masking of small carcinomas. Invenia ABUS 2.0 technology is specifically designed to help clinicians find cancers that may be hidden on a mammogram.

The advantage of this technology is also enabling quick and simple scanning of the entire breast in just a few minutes. It is somewhat faster than traditional mammography, which on average lasts up to 30 minutes and can sometimes be painful, and it is also less uncomfortable for patients.

Better breast image quality compared to traditional mammography, resulting in fewer false positive and false negative findings. This method also does not use ionizing radiation.

Who is this technology especially useful for?

• It is useful for all women in breast cancer screening as a supplement to mammography, and it is an additional diagnostic method that increases the detection of breast cancer
• It is especially useful for women who have dense breast tissue (ACR type C and D), because breast density can make it more difficult to diagnose cancer through conventional mammography.
• Useful for women who have had breast problems in the past, such as cysts or fibroadenomas.
• A major advantage of this technology is in the diagnosis of breast cancer in younger women, who are more likely to develop aggressive forms of breast cancer.
• It is also useful for women who are positive for the BRCA mutation, as well as for women with a family history of breast cancer.

The power of early breast cancer detection

Invenia ABUS 2.0 uses the latest ultrasound innovations and solutions based on artificial intelligence. It helps us in the precise diagnosis of breast cancer.

ABUS and treatment

This new technology provides us with a complete view of the breast and thus helps plastic surgeons achieve better orientation as well as a better surgical approach.

It also helps in monitoring treatment progress with the aim of avoiding complications and the risk of recurrence of cancer.

In short, Invenia™ ABUS 2.0 is the latest ultrasound technology that can impainve the detection of breast cancer in the early stages.

This technology offers advantages compared to traditional mammography, and is especially useful for women with dense breast tissue, for younger women, and women with a family history.

You can view our price list at the following link: PRICE LIST.

If you have a question for us or would like to schedule an appointment, feel free to contact us at 01 2321 970 or fill out the contact form.